New research suggests that a fat hormone in body fat could contribute towards a higher risk of dementia and Alzheimer's disease (AD) in women.
AD is the most usual kind of dementia. The researchers suggest a link between insulin resistance and inflammation, signpost or type 2 diabetes and the development of dementia.
The researchers have confirmed that another possible factor which can contribute to the onset of AD and all-cause dementia is adiponectin.
Adiponectin is a hormone which is derived from visceral fat. It sensitises the body to insulin and has anti-inflammatory properties. It also plays a pivotal role in the metabolism of glucose and lipids.
840 patients of whom 541 were women, were monitored for 13 years and signs of the development of AD and all-cause dementia were evaluated.
During this period, 159 patients got dementia, including 125 cases of AD.
Upon taking into account other dementia risk factors just adiponectin in women was related to an increased risk of all-cause dementia and AD.
Fat Hormone Increases Risk of Dementia in Women
Tue, 03 Jan 2012
Recommended links
Diabetic Travel Insurance for a Single PersonDiabetic Travel Insurance for a Couple
Diabetic Travel Insurance for a Family
Diabetic Travel Insurance for a Single Parent
Insulin Resistance
Insulin in the UK
Using Insulin Abroad
Holiday Travel Insurance
Travelling Long Haul
Type 2 Diabetes
Pregnant Women Need to be Tested for Diabetes
Women Should Exercise More to Reduce Likelihood of Diabetes
Women with Gestational Diabetes Number Estimated
Drug for Diabetes Could Fight Dementia
Diabetes and Dementia Link
Fat Cell Dysfunction Can Trigger Obesity
Low Body Fat Might Not Keep You Protected from Diabetes
High Fat Low Carb Diet Can Correct Kidney Damage
Unhealthy Diets of Fathers Passed on to Daughters
A Daliy Injection which Combats Diabetes and Keeps the Fat Off
Adding Fat Reducing Drug Does not Help Diabetic Hearts
